HPR210 Future BeNeLuxA Success – A Partnership vs a Prescription Model

Since 2015 there has been substantial growth in multi-country collaborations across Europe, driven by the increasing number of expensive high-innovative drugs with medical need. By joining together, countries increase efficiency of their health technology assessment (HTA) processes to achieve greater bargaining power during price negotiations and ensure patients have timely access to affordable medications. BeNeLuxA brings together Austria, Belgium, Ireland, Luxembourg and The Netherlands, with a combined total population of 43 million.
Source: Value in Health - Category: International Medicine & Public Health Authors: Source Type: research